Church & Dwight Co., Inc. — FY 2022 Form 10-K
Business context and reporting period
This filing reports the fiscal year ended December 31, 2022, with comparisons to FY 2021. It is an annual report, not a standalone Q4 earnings report; the provided filing text does not give a clear set of Q4-only financial results. Church & Dwight sells household, personal care and specialty products through three segments: Consumer Domestic, Consumer International and Specialty Products Division (SPD), representing approximately 77%, 17% and 6% of 2022 sales, respectively.
Key financial metrics
| Metric | FY 2022 | FY 2021 |
|---|---|---|
| Net sales | $5,375.6 million | $5,190.1 million |
| Gross profit / margin | $2,250.0 million / 41.9% | $2,263.5 million / 43.6% |
| Operating income / margin | $597.8 million / 11.1% | $1,079.1 million / 20.8% |
| Net income | $413.9 million | $827.5 million |
| Diluted EPS | $1.68 | $3.32 |
| Cash from operations | $885.2 million | $993.8 million |
| Capital expenditures | $178.8 million | $118.8 million |
Sales increased 3.6%; pricing/product mix contributed 6.5%, acquired product lines 3.2%, while volumes declined 5.1% and foreign exchange/other reduced growth by 1.0%. Consumer Domestic sales rose 4.8%, Consumer International sales fell 1.8%, and SPD sales rose 3.7%. Household products generated $2,272.0 million and personal care products $1,859.0 million in sales.
At year-end, cash and cash equivalents were $270.3 million; inventories were $646.6 million, up from $535.4 million. Total debt, net of issuance costs, was approximately $2,673.5 million. Approximately 82% was fixed-rate debt, with a 4.1% weighted average rate; commercial paper and the term loan comprised the remainder. The company reported approximately $1,426 million available through its commercial paper program and revolving credit facility. Operating cash flow fell $108.6 million, reflecting higher working capital and lower cash earnings.
Material changes versus the prior comparable period
- Gross margin declined 170 basis points, primarily from higher labor, commodity, transportation and other manufacturing costs and lower volumes; pricing/mix and productivity partially offset these pressures.
- Operating margin fell 970 basis points. SG&A included a $411.0 million non-cash impairment of FINISHING TOUCH FLAWLESS intangible assets; FY 2021 had instead benefited from a $98.0 million reduction in the related acquisition liability.
- The impairment reduced FY 2022 diluted EPS by $1.26 per share. Reported diluted EPS declined 49.4% year over year.
- Interest expense rose to $89.6 million from $54.5 million, reflecting higher average debt and interest rates.
- Hero Cosmetics was acquired on October 13, 2022 for $546.8 million net of cash acquired; its 2022 annual sales were approximately $179 million. The acquisition was financed with cash and commercial paper borrowings.
Outlook, management commentary and risks
Management expected raw-material and labor shortages and input-cost inflation to persist at least through the first half of 2023. It reported improving fill rates, particularly in household products, and expected improvement to continue across most categories, while cautioning that supply disruptions could persist. Planned 2023 capital expenditures were approximately $250 million, principally for laundry, litter and vitamin manufacturing capacity. Management stated that operating cash flow and borrowing capacity were expected to support capital needs, debt service, dividends and share repurchases.
Key demand concerns included weaker discretionary spending, consumers trading down in water flossers, reduced demand for FINISHING TOUCH FLAWLESS, and slower growth and competition in gummy vitamins. The company identified supply-chain interruptions, inflation, retailer pricing pressure and customer concentration as material risks; Walmart and its affiliates accounted for 24% of sales, and the four largest customers for approximately 42%.
At October 1, 2022, the WATERPIK tradename’s fair value exceeded carrying value by only 7%, and the TROJAN tradename’s by 46%; continued weaker performance could result in further impairment. The company also cited foreign exchange, higher interest rates, competition, regulatory and product-liability exposure, cybersecurity, and geopolitical effects from the Russia-Ukraine war. It had no operations in Russia or Ukraine and suspended sales into Russia and Belarus; those sales were not material. No relevant legal proceedings were disclosed under Item 3, although ordinary-course proceedings and contingencies are described in the notes. Management and Deloitte reported effective internal controls; Deloitte issued unqualified opinions on the financial statements and internal controls.
In February 2023, the Board raised the quarterly dividend 4%, to $0.2725 per share ($1.09 annualized). The company stated that it did not expect the Inflation Reduction Act to have a material effect on its financial position, results or cash flows.
Important facts for investors to verify
- Whether 2023 pricing and productivity gains can offset persistent input-cost inflation without further volume or market-share losses.
- Whether manufacturing capacity and fill rates improve as expected, particularly for vitamins and other supply-constrained products.
- Whether WATERPIK and TROJAN performance supports their intangible-asset valuations, given their disclosed impairment sensitivities.
- How much reported earnings comparisons normalize after the $411.0 million FINISHING TOUCH FLAWLESS impairment and the prior-year acquisition-liability benefit.
- Debt levels, interest costs, liquidity and covenant headroom following the Hero acquisition and new note issuances.
- Customer concentration and retailer decisions, including distribution changes affecting discretionary brands.